Every compound you administer follows a predictable pharmacokinetic lifecycle: it absorbs into the bloodstream, reaches a peak concentration, distributes through tissues, and is gradually eliminated by the body. The rate of elimination is defined by the compound's half-life — the time it takes for the blood concentration to drop by 50%.
When you take a single dose and wait, the compound clears. But when you take repeated doses on a schedule — as in any protocol — each new dose adds to whatever remains from previous doses. The blood concentration does not start from zero each time. It builds.
The point where this buildup stabilizes — where the amount being added by each new dose equals the amount being cleared — is called steady state. At steady state, blood levels follow a consistent cycle of peak and trough that repeats with each dosing interval. This is the pharmacological foundation of every protocol.
The 5-Half-Life Rule
Pharmacokinetics provides a clean mathematical rule: it takes approximately 5 half-lives of consistent dosing to reach steady state. This is not an approximation or a guideline — it is derived directly from the exponential elimination equation.
After each half-life of consistent dosing, a predictable percentage of steady state has been reached:
Saturation Buildup Over Time
At 5 half-lives, you are at approximately 97% of the eventual steady-state concentration. Pharmacologically, this is considered "at steady state." Further dosing produces negligible additional buildup — the system has fully saturated.
The math is the same regardless of the compound, the dose, or the route of administration. What changes is the half-life, which determines how long each step takes in real time.
Real-World Examples
The practical implication of the 5-half-life rule becomes clear when you plug in actual compound half-lives. The time to steady state varies dramatically across different compound types.
BPC-157
t½ ≈ 30 minWith a half-life of approximately 30 minutes, BPC-157 reaches steady state within hours of starting daily dosing. Each dose is almost entirely cleared before the next. This means BPC-157 does not meaningfully accumulate — each dose produces a brief spike and rapid clearance. The body does not build up a persistent blood level; it relies on frequent pulses.
Testosterone Enanthate
t½ ≈ 4.5 daysTestosterone enanthate builds up gradually. With twice-weekly injections, significant overlap occurs between doses. By week 3, blood levels stabilize into a consistent peak-trough pattern. This is why many experienced users recommend not adjusting dose until at least 4 to 6 weeks — you need to reach steady state before the bloodwork reflects the true impact of your protocol.
Semaglutide
t½ ≈ 7 daysSemaglutide has one of the longest half-lives of commonly used peptides. With weekly dosing, each injection adds to substantial residual levels from the previous weeks. It takes approximately 5 weeks of the same dose to fully saturate. This is why many titration protocols gradually increase the dose every 4 weeks — each step needs time to reach its own steady state before the effects can be properly assessed.
Why Saturation Matters
Understanding where you are in the saturation curve answers the most common question people have during the first weeks of a protocol: "is it working?"
If you are at 45% saturation on day 10 of a testosterone protocol, your blood levels have not yet reached the concentration that the protocol is designed to produce. The compound is present and being utilized, but you have not reached the pharmacological conditions where the full effect manifests. Expecting week-12 results at 45% saturation is like expecting to be at the top of a staircase when you are on step 5 of 10.
Conversely, once you reach 90%+ saturation, each subsequent dose is primarily maintaining your levels rather than building them further. This is the maintenance phase — the protocol is fully operational. Any effects you are going to see from this dose will emerge here, not during the ramp-up.
Do not change your protocol during the ramp-up phase unless there is a specific reason. Increasing the dose at 50% saturation does not accelerate reaching steady state at the original dose — it resets the clock for a new, higher steady state. Patience during the first 5 half-lives is the most common advice in the peptide community for good reason.
Saturation and Multi-Compound Stacks
When running a multi-compound stack, each compound in the stack saturates independently. A stack containing BPC-157 (2.5-hour saturation) and testosterone enanthate (3-week saturation) means one compound reaches full effect almost immediately while the other is still building.
This creates an asymmetric experience. The short-half-life compounds are fully operational within days, while the long-half-life compounds are still climbing. Understanding which compounds in your stack are saturated and which are still building provides context for what you are feeling (or not feeling) at any given point.
What Saturation Is and Is Not
A few clarifications that help frame this concept correctly:
- Saturation is not a measure of effectiveness. It is a measure of blood level stability. A compound at 100% saturation is not "more effective" than at 80% — it means the peak-trough cycle has fully stabilized.
- Saturation is dose-independent. Whether you take 100mg or 500mg per week, steady state still takes 5 half-lives. The dose determines the eventual blood level; the half-life determines how long it takes to get there.
- Saturation resets if you miss doses. Consistent dosing is what drives accumulation. Missing doses during the ramp-up period extends the time to steady state. Missing doses after reaching steady state causes levels to decay according to the half-life.
- Saturation assumes consistent dosing intervals. Irregular spacing between doses produces irregular blood levels. The 5-half-life rule applies cleanly when doses are evenly spaced at the prescribed interval.
Visualizing Your Saturation
The saturation curve — a graph of blood concentration over time as doses accumulate toward steady state — is the single most informative visualization for any protocol. It shows exactly where you are in the buildup, when you will reach stable levels, and what the peak-to-trough variation looks like at different points in the protocol.
For long-acting compounds, the curve is a gradually rising staircase where each step is a dose. For short-acting compounds, the curve looks like a series of spikes with minimal carry-over. For intermediate compounds, it is a rising wave that progressively dampens into a stable oscillation.
This is the pharmacokinetic curve that Milligram generates in real time for every compound in your protocol. It takes the abstract concept of steady state and turns it into a concrete, visual answer to "where am I right now?"